These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 12141718

  • 1. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
    Berkowitz RB, Woodworth GG, Lutz C, Weiler K, Weiler J, Moss M, Meeves S.
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
    [Abstract] [Full Text] [Related]

  • 2. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [Abstract] [Full Text] [Related]

  • 3. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Allergy Asthma Proc; 2004 Oct; 25(5):335-43. PubMed ID: 15603207
    [Abstract] [Full Text] [Related]

  • 4. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
    Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R.
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 6. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit.
    Day JH, Briscoe MP, Welsh A, Smith JN, Clark A, Ellis AK, Mason J.
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):533-40. PubMed ID: 9433370
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study.
    Meltzer EO, Casale TB, Gold MS, O'Connor R, Reitberg D, del Rio E, Weiler JM, Weiler K.
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):79-86. PubMed ID: 12546342
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
    Sussman GL, Mason J, Compton D, Stewart J, Ricard N.
    J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.
    Williams BO, Hull H, McSorley P, Frosolono MF, Sanders RL.
    Ann Allergy Asthma Immunol; 1996 May; 76(5):432-8. PubMed ID: 8630717
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed.
    Dockhorn RJ, Williams BO, Sanders RL.
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):204-8. PubMed ID: 8595542
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH, Briscoe MP, Rafeiro E, Ratz JD, Ellis AK, Frankish CW, Chapman D, deGuia EC, Kramer B, Warner C.
    Allergy Asthma Proc; 2005 Feb; 26(4):275-82. PubMed ID: 16270720
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J.
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [Abstract] [Full Text] [Related]

  • 14. Treatment of seasonal allergic rhinitis: a comparison of a combination tablet of terfenadine and pseudoephedrine with the individual ingredients.
    Backhouse CI, Rosenberg RM, Fidler C.
    Br J Clin Pract; 1990 Jul; 44(7):274-9. PubMed ID: 1976379
    [Abstract] [Full Text] [Related]

  • 15. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO, Scheinmann P, Rosado Pinto JE, Bachert C, Hedlin G, Wahn U, Finn AF, Ruuth E.
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [Abstract] [Full Text] [Related]

  • 17. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis.
    Meran A, Morse J, Gibbs TG.
    Rhinology; 1990 Mar; 28(1):33-40. PubMed ID: 1970907
    [Abstract] [Full Text] [Related]

  • 18. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

  • 19. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR, Romero FA, Allan RJ, Phillips PG, Hackman F, Misfeldt J, Casale TB.
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [Abstract] [Full Text] [Related]

  • 20. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH, Briscoe M, Rafeiro E, Chapman D, Kramer B.
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.